ClinicalTrials.govpublic full text
Phase 3 Randomized, Open-Label Study of Guadecitabine vs Treatment Choice in Previously Treated Acute Myeloid Leukemia
acute myeloid leukemia, aml, acute myeloid leukemia, guadecitabine, sgi-110, phase 3, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 831535
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.